Notably, PD patients without GBA1 mutations can exhibit lower levels of glucocerebrosidase enzyme in blood and CNS, further implicating this lysosomal enzyme in the pathogenesis of PD (32,55). This evidence concerns the gene GBA1 and Parkinson disease.